Lihao Meng
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Signaling Pathways in Disease
- Chemical Synthesis and Analysis
- Glycosylation and Glycoproteins Research
Papers in
-
- Advanced Biosensing Techniques and Applications 4
- Ubiquitin and proteasome pathways 2
- Signaling Pathways in Disease 2
- Advanced biosensing and bioanalysis techniques 2
- Oncology 4
- Peptidase Inhibition and Analysis 4
- Co-authors
- Craig M. Crews (5 shared papers)Ny Sin (5 shared papers)Benjamin H. Kwok (2 shared papers)Mikael Elofsson (2 shared papers)Royce Mohan (1 shared paper)William G. Bornmann (1 shared paper)James Wen (1 shared paper)Erik Floor (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Neurochemistry (1 paper)BMC Biotechnology (1 paper)Heritage (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Lihao Meng
13 papers receiving 1.7k citations
Lihao Meng's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 610
- Molecular Biology 1.2k
- Cancer Research 189
- Cellular and Molecular Neuroscience 226
- Cell Biology 187
Countries citing papers authored by Lihao Meng
This map shows the geographic impact of Lihao Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihao Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihao Meng more than expected).
Fields of papers citing papers by Lihao Meng
This network shows the impact of papers produced by Lihao Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihao Meng. The network helps show where Lihao Meng may publish in the future.
Co-authors
The 22 scholars most cited alongside Lihao Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity Hit paper breakdown → | 1999 | 802 |
| 2 | The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2 Hit paper breakdown → | 1997 | 533 |
| 3 | 1999 | 163 | |
| 4 | 1995 | 70 | |
| 5 | 1998 | 50 | |
| 6 | 1996 | 41 | |
| 7 | 1998 | 31 | |
| 8 | 2008 | 21 | |
| 9 | 2010 | 14 | |
| 10 | 2021 | 9 | |
| 11 | 2012 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2009 | 1 | |
| 14 | 2026 | 0 |
About Lihao Meng
Lihao Meng is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Organic Chemistry, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Advanced Biosensing Techniques and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Ubiquitin and proteasome pathways (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Signaling Pathways in Disease (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Neuroscience and Neural Engineering (1 paper). The work is most often cited by research in Oncology (610 citations), Molecular Biology (1.2k citations), Cancer Research (189 citations), Cellular and Molecular Neuroscience (226 citations) and Cell Biology (187 citations). Lihao Meng has collaborated with scholars based in United States and China. Frequent co-authors include Craig M. Crews, Ny Sin, Benjamin H. Kwok, Mikael Elofsson, Royce Mohan, William G. Bornmann, James Wen, Erik Floor, Kyung Bo Kim and Weiqing Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neurochemistry, BMC Biotechnology, Heritage and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.